World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
20550
World Ranking
15796
National Ranking
513

Overview

Olivier Fain is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine, with a primary focus on rheumatology, genetics, hematology, immunology, and pathology and forensic medicine. Their research work is concentrated in several key topics including coagulation, bradykinin, polyphosphates, and angioedema; otitis media and relapsing polychondritis; systemic lupus erythematosus; vasculitis and related conditions; renal diseases and glomerulopathies; systemic sclerosis and related diseases; and eosinophilic disorders and syndromes.

Their publication record includes numerous papers in prominent journals. Recent papers include:

  • Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients, 2021, British Journal of Dermatology
  • A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML, 2022, Leukemia
  • Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients, 2022, RMD Open
  • Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts, 2020, The Lancet Rheumatology
  • Endometriosis with infertility: A comprehensive review on the role of immune deregulation and immunomodulation therapy, 2020, American Journal of Reproductive Immunology

Fain has published prolifically in several journals, with the most frequent venues being:

  • La Revue de Médecine Interne
  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • RMD Open
  • Blood

Their collaborations include frequent co-authors such as:

  • A. Mékinian
  • Pierre Fenaux
  • Vincent Jachiet
  • Delphine Gobert
  • Lionel Adès

Olivier Fain's main fields of study encompass 452 publications in medicine, with significant contributions in the subfields of rheumatology (96 publications), genetics (91 publications), hematology (61 publications), immunology (43 publications), and pathology and forensic medicine (36 publications).

Best Publications

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier

  • Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    JE Gottenberg;L Guillevin;O Lambotte;B Combe

  • Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Benjamin Terrier;Zahir Amoura;Philippe Ravaud;Eric Hachulla

  • Vasculitides associated with malignancies: analysis of sixty patients.

    Olivier Fain;Mohamed Hamidou;Patrice Cacoub;Bertrand Godeau

  • Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

    Bertrand Godeau;Raphael Porcher;Olivier Fain;François Lefrère

  • Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

    Bertrand Godeau;Sylvie Chevret;Bruno Varet;François Lefrère

  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

    Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel

  • Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

    Boris Duchemann;Isabella Annesi-Maesano;Camille Jacobe de Naurois;Shreosi Sanyal

  • Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis.

    Michael Soussan;Patrick Nicolas;Catherine Schramm;Sandrine Katsahian

  • High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

    Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Musculoskeletal manifestations of scurvy

    Olivier Fain

  • Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.

    Rakiba Belkhir;Sébastien Le Burel;Laetitia Dunogeant;Aurélien Marabelle

  • Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

    H Vallet;S Riviere;A Sanna;A Deroux

  • Population‐based prevalence study of Behçet's disease: Differences by ethnic origin and low variation by age at immigration

    Alfred Mahr;Linda Belarbi;Bertrand Wechsler;Dominique Jeanneret

  • Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.

    LOïc Guillevin;Olivier Fain;François Lhote;Bernard Jarrousse

  • Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

    Nathalie Costedoat-Chalumeau;Lionel Galicier;Lionel Galicier;Olivier Aumaître;Camille Francès

  • Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study

    Arsène Mekinian;Eric Grignano;Thorsten Braun;Olivier Decaux

  • Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.

    Nathalie Costedoat-Chalumeau;Zahir Amoura;Jean-Marc Lupoglazoff;Du Le Thi Huong

  • Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

    Sébastien Le Burel;Stéphane Champiat;Christine Mateus;Aurélien Marabelle

Frequent Co-Authors

Pierre Fenaux
Pierre Fenaux Université Paris Cité
Patrice Cacoub
Patrice Cacoub Sorbonne University
Lionel Galicier
Lionel Galicier Université Paris Cité
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Fabrice Carrat
Fabrice Carrat Sorbonne University
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Olivier Lambotte
Olivier Lambotte University of Paris-Saclay
Eric Hachulla
Eric Hachulla University of Lille
Xavier Puéchal
Xavier Puéchal Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medicine in the USA opens doors to many other healthcare careers. For those interested in patient care but not eager to take admissions tests like TEAS or HESI, do all nursing schools require the teas is a common question. The answer: several nursing schools now offer programs without these exam requirements, making entry more accessible.

If you are inclined toward leadership roles and hospital management, a degree in healthcare administration can be completed online, allowing you to advance without pausing your current commitments. For registered nurses wanting to become family nurse practitioners, adn to fnp programs can help you bridge your credentials quickly and efficiently.

Interested in preventive medicine or holistic health? Earning a nutrition bachelor degree online can lead to careers in wellness coaching, research, or community health programs. Each of these paths provides flexibility, potential for career advancement, and the satisfaction of making a difference in healthcare.

Best Scientists Citing Olivier Fain

Trending Scientists

Recently Published Articles